Braskem 6-K: EGM okays bylaw changes; approvals up to 80.2%
Braskem S.A. filed a Form 6‑K furnishing the final synthetic voting map from its Extraordinary General Meeting held on November 13, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Braskem S.A. filed a Form 6‑K furnishing the final synthetic voting map from its Extraordinary General Meeting held on November 13, 2025. Shareholders approved all items, including the replacement of one Board member appointed by Novonor S.A. and NSP Investimentos S.A., to serve until the Annual General Meeting that will resolve the 2025 financial statements.
Governance changes to the Bylaws were also approved: an update to article 2 to align the corporate purpose with current activities; the inclusion of detailed rules for electing the Board of Directors; and an amendment to article 26 to update Board approval thresholds, authorize the Board to maintain or adjust those thresholds, and remove from the Board the responsibility to select and replace independent auditors of subsidiaries. A consolidation of the Bylaws reflecting these changes was approved. Approval levels ranged from 78.1%–80.2% of share capital, including 97.9% of the total number of ordinary shares and 52.3%–57.1% of the total number of preference shares.
Insights
All EGM proposals passed with strong votes; governance clarified.
The meeting approved a director replacement to complete the current term and several Bylaw refinements that standardize corporate purpose language, formalize Board election procedures, and recalibrate Board approval thresholds. These are procedural governance updates rather than operational shifts.
Support was broad, with approvals spanning 78.1%–80.2% of share capital and 97.9% of ordinary shares on the main items. The article 26 change also authorizes the Board to maintain or adjust thresholds and transfers subsidiary auditor selection away from the Board.
The outcomes are administrative in nature. Future disclosures in company filings may provide additional detail on implementation timing; no cash effects are indicated in the excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How strong was support for Braskem’s EGM proposals (BAK)?
What does the Board member replacement at Braskem (BAK) cover?
What changed in Braskem’s Bylaws (BAK) regarding the corporate purpose?
What governance procedures did Braskem (BAK) add for Board elections?
How did Braskem (BAK) modify article 26 of its Bylaws?
AI-generated analysis. How Rhea-AI works. Not financial advice.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2025
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
BRASKEM S.A
C.N.P.J. No. 42.150.391/0001-70
NIRE 29300006939
PUBLICLY HELD COMPANY
FINAL SYNTHETIC VOTING MAP
Items on the agenda of the Extraordinary General Meeting held on
November 13, 2025
| Resolution code | Description of the resolution | Resolution vote | Number of shares | (%) of Share Capital | (%) of the Total Number of Ordinary Shares | (%) of the Total Number of Preference Shares | |
| Number of Shares (Ordinary) | Number of Shares (Preferred) | ||||||
| 1 | Replacement of one (1) effective member of the Company’s Board of Directors appointed by Novonor S.A. – Under Judicial Reorganization (“Novonor”) and by NSP Investimentos S.A. – Under Judicial Reorganization (“NSP Inv.”), to complete the remaining term of office, until the Annual General Meeting that will resolve on the Company’s financial statements for the fiscal year ending on December 31, 2025. | APPROVALS | 442,189,790 | 181,055,567 | 78.2% | 97.9% | 52.4% |
| REJECTIONS | 19,750 | 16,387,070 | 2.1% | 0.0% | 4.7% | ||
| ABSTENTIONS | 2,942 | 89,037 | 0.0% | 0.0% | 0.0% | ||
1
| 2 | Amendment to article 2 of the Company's Bylaws, to improve its wording by aligning the description of the corporate purpose with the current reality of the activities performed by the Company. | APPROVALS | 442,190,789 | 197,261,650 | 80.2% | 97.9% | 57.1% |
| REJECTIONS | 18,727 | 192,235 | 0.0% | 0.0% | 0.1% | ||
| ABSTENTIONS | 2,966 | 78,341 | 0.0% | 0.0% | 0.0% | ||
| 3 | Inclusion of a provision in the Company's Bylaws to detail the rules and procedures for the election of the Board of Directors. | APPROVALS | 442,194,213 | 180,717,541 | 78.1% | 97.9% | 52.3% |
| REJECTIONS | 17,201 | 16,744,175 | 2.1% | 0.0% | 4.8% | ||
| ABSTENTIONS | 1,068 | 69,798 | 0.0% | 0.0% | 0.0% | ||
| 4 | Amendment to article 26 of the Company's Bylaws to: (a) update the approval thresholds of the Board of Directors; (b) authorize the Board of Directors to decide on the maintenance or monetary adjustment of such thresholds; and (c) remove from the Board of Directors’ responsibilities the selection and replacement of the independent auditors of the subsidiaries. | APPROVALS | 442,187,137 | 197,112,441 | 80.2% | 97.9% | 57.0% |
| REJECTIONS | 18,202 | 351,213 | 0.0% | 0.0% | 0.1% | ||
| ABSTENTIONS | 7,143 | 68,454 | 0.0% | 0.0% | 0.0% | ||
| 5 | Due to the amendments resolved in items 2 to 4 above, resolve on the consolidation of the Company's Bylaws, including the renumbering of articles and paragraphs as applicable. | APPROVALS | 442,190,990 | 197,367,398 | 80.2% | 97.9% | 57.1% |
| REJECTIONS | 18,326 | 104,633 | 0.0% | 0.0% | 0.0% | ||
| ABSTENTIONS | 3,166 | 60,079 | 0.0% | 0.0% | 0.0% |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 13, 2025
| BRASKEM S.A. | |||
| By: | /s/ Felipe Montoro Jens | ||
| Name: | Felipe Montoro Jens | ||
| Title: | Chief Financial Officer | ||
DISCLAIMER ON FORWARD-LOOKING STATEMENTS
This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.